☆ 4.4 Article

The efficacy and timing of adjuvant chemotherapy in upper tract urothelial carcinoma

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Add to Collection

Review Oncology

Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data

Angela Dalia Ricci et al.

Summary: The systematic review and meta-analysis show that platinum-based adjuvant chemotherapy is associated with improved disease-free survival and a modest overall survival benefit in patients with upper tract urothelial carcinoma.

ANTI-CANCER DRUGS (2022)

Add to Collection

Article Oncology

Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system

Yan Lu et al.

Summary: Previous studies may have overestimated the survival benefits of early initiation of adjuvant chemotherapy, possibly due to time-related biases. Further research is needed to clarify these findings.

BMC CANCER (2022)

Add to Collection

Article Oncology

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer

Yuanyuan Chen et al.

Summary: Irregular delay of adjuvant chemotherapy (IDacT) has a significant impact on the prognosis of stage II-III colorectal cancer (CRC) patients, and the effect of delay per cycle (DpC) is more pronounced, resulting in significantly worse disease-free survival (DFS) for patients with longer DpC.

BMC CANCER (2022)

Add to Collection

Article Pharmacology & Pharmacy

Exploring the adverse effects of chemotherapeutic agents used in the treatment of cervical and ovarian cancer from the patients' perspective: a content analysis of the online discussion forums

Sulaf Assi et al.

Summary: This study aimed to explore the adverse effects of chemotherapeutic agents used in the treatment of ovarian and cervical cancer by analysing patients' views posted in online discussion forums. Patients have positive perceptions about their treatment, but there are differences in adverse effects, such as fatigue and nausea being more prominent in cervical cancer patients taking cisplatin, and neuropathy and fatigue being the major adverse effects in ovarian cancer patients treated with carboplatin and paclitaxel.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2021)

Add to Collection

Article Oncology

Adverse drug reactions associated with chemotherapeutic agents used in breast cancer: Analysis of patients' online forums

Sulaf Assi et al.

Summary: Breast cancer is the most common type of cancer in women worldwide. Chemotherapy can have varying benefits depending on the treatment regimen and tumor characteristics. Adverse drug reactions associated with chemotherapeutic agents can impact treatment outcomes. Through analysis of online discussion forums, it was found that patients' experiences with adverse drug reactions were mainly related to the nervous and immune systems, as well as themes of peer advice, self-medication, and lifestyle changes.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2021)

Add to Collection

Review Urology & Nephrology

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

Morgan Roupret et al.

Summary: The updated EAU guidelines on UTUC aim to assist clinicians in evidence-based management, providing recommendations on diagnosis, risk stratification, radical and conservative treatment, and prognostic factors. Due to the rarity of UTUC, there is insufficient data to provide strong recommendations. Recommendations are based on the 2017 TNM classification and emphasize individualized treatment based on proposed risk stratification.

EUROPEAN UROLOGY (2021)

Add to Collection

Article Oncology

Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

Giuseppe Floris et al.

Summary: In nonunderweight triple-negative breast cancer (TNBC) patients, high levels of stromal tumor-infiltrating lymphocytes (sTIL) can predict pathological complete response (pCR) and significantly impact survival in lean patients, while having a lesser effect on heavier patients.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Add to Collection

Article Oncology

A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder

Amarnath Challapalli et al.

Summary: The combination of cabazitaxel and cisplatin shows promising efficacy with a higher response rate in neoadjuvant treatment of muscle-invasive bladder cancer. The regimen is well-tolerated and may provide improved outcomes compared to conventional cisplatin/gemcitabine therapy. Further evaluation in a phase III study is warranted to confirm these findings.

CLINICAL GENITOURINARY CANCER (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Roles for growth factors and mutations in metastatic dissemination

Nishanth Belugali Nataraj et al.

Summary: Cancer is initiated by specific genetic aberrations, leading to a multi-step metastatic process involving vascular dissemination. While mutagenesis establishes primary tumors, reversible epigenetic processes underlie micro-metastases. Understanding the complexity of metastasis, particularly the roles of growth factors, is crucial for developing anti-metastasis interventions.

BIOCHEMICAL SOCIETY TRANSACTIONS (2021)

Add to Collection

Review Urology & Nephrology

The incidence and prevalence of upper tract urothelial carcinoma: a systematic review

Ahmed Soualhi et al.

Summary: Upper tract urothelial carcinoma (UTUC) is rare and its incidence varies by age, geographical region, and occupation. More research is needed to understand the prevalence and risk factors of UTUC to assess its disease burden.

BMC UROLOGY (2021)

Add to Collection

Article Oncology

Clinical impact of postoperative interval until adjuvant chemotherapy following curative gastrectomy for advanced gastric cancer

Yusuke Takashima et al.

Summary: The study suggests that a delay of more than 7 weeks in starting adjuvant chemotherapy after surgery can have a negative impact on the prognosis of gastric cancer patients, while a cumulative S-1 dose exceeding 12,000 mg/m(2) may be a key factor in mitigating this negative effect.

JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens

Olivia A. Do et al.

Summary: The optimal chemotherapy regimen for metastatic urothelial carcinoma following previous cisplatin-based chemotherapy remains unclear. Platinum-based first-line chemotherapy is more beneficial than non-platinum-based chemotherapy for patients who received prior perioperative and/or peri-radiation cisplatin-based chemotherapy at least 1 year ago. In cases where chemotherapy is administered more than a year after prior cisplatin-based chemotherapy, returning to platinum-based chemotherapy is associated with superior overall survival.

CLINICAL GENITOURINARY CANCER (2021)

Add to Collection

Article Urology & Nephrology

Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma

Vitaly Margulis et al.

JOURNAL OF UROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

Alison Birtle et al.

LANCET (2020)

Add to Collection

Article Oncology

Timing of adjuvant chemotherapy and overall survival following radical cystectomy

Joshua S. Jue et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)

Add to Collection

Review Oncology

Delaying adjuvant chemotherapy in advanced gastric cancer patients: Risk factors and its impact on survival outcome

Bochao Zhao et al.

CURRENT PROBLEMS IN CANCER (2020)

Add to Collection

Review Oncology

Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis

Fahad Quhal et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Oncology

Delayed initiation of adjuvant chemotherapy in older women with breast cancer

Demetria Smith-Graziani et al.

CANCER MEDICINE (2020)

Add to Collection

Article Oncology

Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial

Maxime J. M. van der Valk et al.

RADIOTHERAPY AND ONCOLOGY (2020)

Add to Collection

Article Oncology

Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset

Koki Nakanishi et al.

GASTRIC CANCER (2019)

Add to Collection

Review Medicine, General & Internal

Laparoscopic versus open nephroureterectomy for upper urinary tract urothelial carcinoma A systematic review and meta-analysis

Feng Liu et al.

MEDICINE (2018)

Add to Collection

Article Urology & Nephrology

Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study

Tohru Nakagawa et al.

WORLD JOURNAL OF UROLOGY (2017)

Add to Collection

Article Oncology

Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery

Michelle C. Salazar et al.

JAMA ONCOLOGY (2017)

Add to Collection

Article Oncology

Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery

A. Kaito et al.

EJSO (2017)

Add to Collection

Article Oncology

Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study

K. S. Tewari et al.

ANNALS OF ONCOLOGY (2016)

Add to Collection

Article Oncology

Time to the Initiation of Adjuvant Chemotherapy Does Not Impact Survival in Patients With Resected Pancreatic Cancer

Katelin A. Mirkin et al.

CANCER (2016)

Add to Collection

Article Oncology

Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer

Matthew D. Galsky et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

Add to Collection

Article Oncology

Factors Implicated for Delay of Adjuvant Chemotherapy in Colorectal Cancer: A Meta-analysis of Observational Studies

George Malietzis et al.

ANNALS OF SURGICAL ONCOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

Factors Affecting Use and Delay (≥8 Weeks) of Adjuvant Chemotherapy after Colorectal Cancer Surgery and the Impact of Chemotherapy-Use and Delay on Oncologic Outcomes

Ik Yong Kim et al.

PLOS ONE (2015)

Add to Collection

Article Oncology

Proper Timing of Adjuvant Chemotherapy Affects Survival in Patients with Stage 2 and 3 Gastric Cancer

Hyung Soon Park et al.

ANNALS OF SURGICAL ONCOLOGY (2015)

Add to Collection

Article Surgery

Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer

Ryan P. Merkow et al.

ANNALS OF SURGERY (2014)

Add to Collection

Review Urology & Nephrology

Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins

David A. Green et al.

JOURNAL OF UROLOGY (2013)

Add to Collection

Article Surgery

Improving Postoperative Immune Status and Resistance to Cancer Metastasis A Combined Perioperative Approach of Immunostimulation and Prevention of Excessive Surgical Stress Responses

Yael Goldfarb et al.

ANNALS OF SURGERY (2011)

Add to Collection

Article Oncology

Association Between Receipt and Timing of Adjuvant Chemotherapy and Survival for Patients With Stage III Colon Cancer in Alberta, Canada

Isac S. F. Lima et al.

CANCER (2011)

Add to Collection

Article Oncology

Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis

Gaetan Des Guetz et al.

EUROPEAN JOURNAL OF CANCER (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.